Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Tumor targeting with a Tc-99m-labeled AS1411 aptamer in prostate tumor cells
Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group
Tumour but not stromal expression of beta 3 integrin is essential, and is required early, for spontaneous dissemination of bone-metastatic breast cancer
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model
Tumour Progression and Spontaneous Regression in the Lewis Rat Sarcoma Model
Tumors of the Ear and Lateral Skull Base: Part 2 Preface
Tumor-secreted Hsp90 Subverts Polycomb Function to Drive Prostate Tumor Growth and Invasion
Tumor-environment biomimetics delay peritoneal metastasis formation by deceiving and redirecting disseminated cancer cells
涂膜对油炸猪肉丸品质的影响研究
Tumor necrosis factor-alpha reduces beta-amyloid accumulation primarily by lowering cellular prion protein levels in a brain endothelial cell line
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-kappa B-inducing kinase (NIK) and noncanonical NF-kappa B signaling
Tumor Marker Usage and Medical Care Costs Among Older Early-Stage Breast Cancer Survivors
Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-beta 1 in orchestrating profibrotic responses
Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas
Tumor suppression effects of myoepithelial cells on mice breast cancer
Tumor necrosis factor-alpha expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification
Tumor suppressors in follicular lymphoma
Tumor suppressive effects of WEE1 gene silencing could not enhance immunopotentiation effects of CD80 and 4-1BBL co-stimulation in human T cells
Tumor size, stage and grade alterations of urinary peptidome in RCC
Tumor-suppressive effects of natural-type interferon-beta through CXCL10 in melanoma
Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis
Tumor Volume in Insignificant Prostate Cancer: Increasing Threshold Gains Increasing Risk
Tumor angiogenesis: when the Tree of Life turns bad
Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes
Tumors of the Ear and Lateral Skull Base: Part I Preface
Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p
Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring
Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice
Tumoral acidic pH-responsive MPEG-poly(beta-amino ester) polymeric micelles for cancer targeting therapy
Tumor Targeting Chitosan Nanoparticles for Dual-Modality Optical/MR Cancer Imaging
Tumor suppressor QM-like gene from disk abalone (Haliotis discus discus): Molecular characterization and transcriptional analysis upon immune challenge
Tumour suppressor function of MDA-7/IL-24 in human breast cancer
Tumor-Targeting Peptide Conjugated pH-Responsive Micelles as a Potential Drug Carrier for Cancer Therapy
Tumor budding as a prognostic marker in laryngeal carcinoma
Tumor grade-related thallium-201 uptake in chondrosarcomas
Tumor-specific mutation and downregulation of ING5 detected in oral squamous cell carcinoma
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: Importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drug
Tumor necrosis factor alpha (-308), interleukin-6 (-174) and interleukin-10 (-1082) gene polymorphisms in polycystic ovary syndrome
Tumor Spectrum in Children With Noonan Syndrome and SOS1 or RAF1 Mutations
Tumor necrosis factor alpha, interleukin-6 and interleukin-10 polymorphisms in preeclampsia
Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus
Tumour and tumour-like lesions of the patella - a multicentre experience (vol 19, pg 701, 2009)
Tumor-specific Crosslinking of GITR as Costimulation for Immunotherapy
Tumor budding predicts response to anti-EGFR therapies in metastatic colorectal cancer patients
Tumour tissue: who is in control?
Tumor vasculature as target for therapeutic intervention
Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity
Tumour necrosis factor a blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study
Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate
Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: Sequential perfusion-CT findings
Tumor Necrosis Factor and Interferon-gamma Down-regulate Klotho in Mice With Colitis
Tumor doubling time after initial response to transarterial chemoembolization in patients with hepatocellular carcinoma
Tumor Size Predicts the Biological Behavior and Influence of Operative Modalities in Hepatocellular Carcinoma
Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis
Tumor laterality in early ovarian cancer: influence on left-right asymmetry of pelvic lymph nodes
Tumor in the lesser sac
Tumorigenic Role of Podoplanin in Esophageal Squamous-Cell Carcinoma
Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats
Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?
Tumor-targeted intracellular delivery of anticancer drugs through the mannose-6-phosphate/insulin-like growth factor II receptor
Tumor vessel biology in pediatric intracranial ependymoma Clinical article
Tumor Characteristics of Urothelial Carcinoma on Multidetector Computerized Tomography Urography
Tumor Suppressor PAX6 Functions as Androgen Receptor Co-Repressor to Inhibit Prostate Cancer Growth
Tumour-Derived Microvesicles (TMV) Mimic the Effect of Tumour Cells on Monocyte Subpopulations
Tumor necrosis factor-alpha decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes
Tumor Necrosis Factor (TNF) and Lymphotoxin-alpha (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph Consortium
Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia
Tumor Necrosis Factor alpha and Regulation of Adipose Tissue
Tumor-mediated liver X receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses
Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline
Tumor Necrosis Factor-alpha rs361525 Polymorphism Is Associated with Increased Local Production and Downstream Inflammation in Chronic Obstructive Pulmonary Disease
Tumor Risks and Genotype-Phenotype-Proteotype Analysis in 358 Patients With Germline Mutations in SDHB and SDHD
Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer
Tumour Cannabinoid CB1 Receptor and Phosphorylated Epidermal Growth Factor Receptor Expression Are Additive Prognostic Markers for Prostate Cancer
Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers
Tumour-stromal interactions in acid-mediated invasion: A mathematical model
Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract
Tumor suppression by p53: making cells senescent
Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 Hemochromatosis and Iron Overload Screening (HEIRS) Study participants
Tumor Vessels Are Eph-ing Complicated
Tumor motion prediction with the diaphragm as a surrogate: a feasibility study